Lactulose (Lactulose)

Trade Name : LACTULOSE

Pharmaceutical Associates, Inc,

SOLUTION

Strength 10 g/15mL

LACTULOSE Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Lactulose (Lactulose) which is also known as LACTULOSE and Manufactured by Pharmaceutical Associates, Inc,. It is available in strength of 10 g/15mL per ml. Read more

Lactulose (Lactulose) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • CI05770219n n n n n n R02/19n n n n n n
  • Rx ONLY
  • Lactulose is a synthetic disaccharide in solution form for oral administration. Each 15 mL of Lactulose Solution contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose, and 1.2 g or less of other sugars). Also contains FD&C Yellow No. 6, purified water, and flavoring. Sodium hydroxide used to adjust pH. The pH range is 2.5 to 6.5.
  • Lactulose is a colonic acidifier which promotes laxation.
  • The chemical name for lactulose is 4-0-u00df-D-galactopyranosyl-D-fructofuranose. It has the following structural formula:
  • The molecular weight is 342.30. It is freely soluble in water.
  • Lactulose is poorly absorbed from the gastrointestinal tract, and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose solution reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents. This in turn causes an increase in stool water content and softens the stool.
  • Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce the desired bowel movement.
  • Lactulose solution given orally to man and experimental animals resulted in only small amounts reaching the blood.
  • Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.
  • For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
  • Since lactulose solution contains galactose (less than 1.6 g/15 mL), it is contraindicated in patients who require a low galactose diet.
  • A theoretical hazard may exist for patients being treated with lactulose solution who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of Hn n n n n n gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution. Insufflation of COn n n n n n as an additional safeguard may be pursued but is considered to be a redundant measure.n nn n nn
  • No data
  • Precise frequency data are not available.
  • Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia, and hypernatremia.
  • Nausea and vomiting have been reported.
  • To report SUSPECTED ADVERSE REACTIONS, contact Pharmaceutical Associates, Inc. at 1-800-845-8210.
  • No data
  • The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement.
  • Note: Some patients have found that lactulose solution may be more acceptable when mixed with fruit juice, water or milk.
  • NDC 0121-0577-08:u00a0u00a0u00a0u00a08 fl oz (237 mL) bottlesn n n n n n NDC 0121-0577-16:u00a0u00a0u00a0u00a016 fl oz (473 mL) bottlesn n n n n n NDC 0121-0577-32:u00a0u00a0u00a0u00a032 fl oz (946 mL) bottlen nn n nn
  • NDC 0121-4577-15:u00a0u00a0u00a0u00a015 mL unit dose cupn n n n n n NDC 0121-4577-40:u00a0u00a0u00a0u00a0Case contains 40 unit dose cups of 15 mL (0121-4577-15) packaged in 4 trays of 10 unit dose cups each.n nn n nn
  • NDC 0121-4577-06:u00a0u00a0u00a0u00a0Case contains 96 unit dose cups of 15 mL (0121-4577-15) packaged in 6 cartons of 16 unit dose cups each.
  • NDC 0121-1154-30:u00a0u00a0u00a0u00a030 mL unit dose cupn n n n n n NDC 0121-1154-40:u00a0u00a0u00a0u00a0Case contains 40 unit dose cups of 30 mL (0121-1154-30) packaged in 4 trays of 10 unit dose cups each.n n n n n n NDC 0121-1154-00:u00a0u00a0u00a0u00a0Case contains 100 unit dose cups of 30 mL (0121-1154-30) packaged in 10 trays of 10 unit dose cups each.n nn n nn
  • NDC 0121-1154-06:u00a0u00a0u00a0u00a0Case contains 96 unit dose cups of 30 mL (0121-1154-30) packaged in 6 cartons of 16 unit dose cups each.
  • Lactulose solution contains lactulose 667 mg/mL (10 g/15 mL).
  • Store at controlled room temperature, 20u00b0-25u00b0C (68u00b0-77u00b0F). [See USP] Do not freeze.
  • Under recommended storage conditions, a normal darkening of color may occur. Such darkening is characteristic of sugar solutions and does not affect therapeutic action. Prolonged exposure to temperatures above 30u00b0C (86u00b0F) or to direct light may cause extreme darkening and turbidity which may be pharmaceutically objectionable. If this condition develops, do not use.
  • Prolonged exposure to freezing temperatures may cause change to a semisolid, too viscous to pour. Viscosity will return to normal upon warming to room temperature.
  • Keep tightly closed.
  • Dispense in original container or tight, light-resistant container with a child-resistant closure.
  • To the Pharmacist: When ordering this product, include the product number (or NDC) in the description.
  • Arrayn- pain n n n n n Pharmaceuticaln n n n n n Associates, Inc.n n n n n n
  • R02/19
  • NDC 0121-0577-16
  • Lactulose Solution USP
  • 10 g/15 mL
  • Each 15 mL contains:
  • Dispense in original container or tight, light-resistantn n n n n n container with a child-resistant closure.n nn n nn
  • To the Pharmacist: When ordering this product,n n n n n n include the product number (or NDC) in then n n n n n description.n nn n nn
  • Rx ONLY
  • 16 fl oz (473 mL)
  • Arrayn- Pharmaceuticaln n n n n n Associates, Inc.n n n n n n
  • UNIT DOSEn n n n n n Delivers 15 mLn n n n n n NDC 0121-4577-15n n n n n n
  • Arrayn- Arrayn- Arrayn- Arrayn- Arrayn- 10 g/15 mL
  • Indication: For the treatmentn n n n n n of constipation. See Insert.n n n n n n FOR INSTITUTIONAL USE ONLYn n n n n n
  • Rx ONLY
  • F45771500
  • UNIT DOSEn- 30 mL
  • Arrayn- Arrayn- Arrayn- Arrayn- Array
  • Indication: For the treatmentn n n n n n of constipation. See Insert.n n n n n n FOR INSTITUTIONAL USE ONLYn n n n n n
  • Rx ONLY
  • A45773001

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.